Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Journey Medical (DERM) Non Operating Income (2020 - 2026)

Journey Medical filings provide 6 years of Non Operating Income readings, the most recent being -$804000.0 for Q4 2025.

  • On a quarterly basis, Non Operating Income fell 23.31% to -$804000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$3.2 million, a 242.51% decrease, with the full-year FY2025 number at -$3.2 million, down 242.51% from a year prior.
  • Non Operating Income hit -$804000.0 in Q4 2025 for Journey Medical, down from -$786000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $504000.0 in Q3 2024 to a low of -$4.4 million in Q4 2021.
  • Median Non Operating Income over the past 5 years was -$606000.0 (2022), compared with a mean of -$760950.0.
  • Biggest five-year swings in Non Operating Income: plummeted 2016.02% in 2021 and later soared 239.61% in 2024.
  • Journey Medical's Non Operating Income stood at -$4.4 million in 2021, then soared by 85.46% to -$634000.0 in 2022, then soared by 113.72% to $87000.0 in 2023, then plummeted by 849.43% to -$652000.0 in 2024, then fell by 23.31% to -$804000.0 in 2025.
  • The last three reported values for Non Operating Income were -$804000.0 (Q4 2025), -$786000.0 (Q3 2025), and -$860000.0 (Q2 2025) per Business Quant data.